What ABEC does

ABEC is a privately held bioprocess engineering solutions provider founded in 1974 and headquartered in Bethlehem, Pennsylvania. The company designs, manufactures, and services custom biopharmaceutical manufacturing systems—including CSR single-use bioreactors up to 6,000L, stainless-steel bioreactors and fermenters up to 30,000L+, and hybrid bioprocessing platforms—for biologic drug manufacturers, contract manufacturing organizations (CMOs), and cell and gene therapy developers. ABEC's technology stack includes the Advanced Therapy Bioreactor (ATB) for perfusion-driven cell therapy workflows, large-scale Tangential Flow Filtration (TFF) systems, the Synaptic HMI automation platform supporting Emerson DeltaV and Rockwell PlantPAx, and Process Sciences capabilities using CFD, FEA, and DoE for scale-up validation.

The company operates five manufacturing facilities totaling over 34,150 m² across the United States and Ireland, including three ISO-7 cleanrooms for single-use disposable container manufacturing, and maintains a global service network of 3,000 technicians supporting an installed base of 50,000+ bioprocess systems worldwide. ABEC monetizes through capital equipment sales for large-scale facility build-outs (e.g., WuXi Biologics Dundalk delivered in 26 months), recurring service contracts covering preventive maintenance, vessel services, modifications and retrofits, and OEM parts supply (20,000+ parts shipped 7 days a week). Go-to-market is direct enterprise sales to biopharma companies from conceptual design through validation and lifecycle support.

Customer concentration skews to large enterprise biopharma manufacturers, with named anchors including Eli Lilly, WuXi Biologics, Samsung Biologics, Fujifilm Diosynth Biotechnologies, and Thermo Fisher Scientific. A June 2025 announced acquisition by Magnesium Capital signals an ownership transition likely to accelerate growth investment. The company's differentiator is its claim to be the only global supplier offering fully customized single-use, stainless-steel, and hybrid bioprocess solutions—a custom-engineering model contrasting with competitors' standard catalog products.

Name

ABEC

Legal name

ABEC, Inc.

Website

http://www.abec.com

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

251–500 employees

Short description

ABEC is a private bioprocess engineering company that designs, manufactures, and services custom single-use, stainless-steel, and hybrid bioreactor systems for biopharmaceutical manufacturers, CMOs, and cell/gene therapy developers across a global installed base of 50,000+ systems.

Ownership category

akta.pro rank

Product category

Bioprocess Manufacturing Equipment

NAICS

Other General Purpose Machinery Manufacturing (3339), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

General Industrial Machinery & Equipment (3560), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA)

akta.pro secondary industries

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies) (HLAGAGAH), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE)

Keywords

• Biopharmaceutical manufacturing
• Single-use bioreactors
• Stainless steel bioreactors
• Bioprocess engineering
• Fermentation equipment

Headquarters

HQ city

Bethlehem

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Infrastructure, Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Biopharmaceutical Manufacturing Systems: ABEC designs, engineers, and manufactures custom bioprocess systems including single-use bioreactors, stainless-steel bioreactors, fermenters, and hybrid systems. Revenue is generated through capital equipment sales to biopharma manufacturers.
2. Service & Support: Comprehensive lifecycle service including outsourced maintenance, vessel services, modifications and retrofits, part supply, automation support, engineering and consulting, and process science support. Services delivered globally through a network of 3,000 service technicians.
3. Parts Supply: Supply of OEM and qualified replacement parts supporting routine maintenance, urgent repairs, and long-term lifecycle planning. Access to 20,000+ parts shipped 7 days a week.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

ABEC designs, engineers, and manufactures custom bioprocess systems for the biopharmaceutical industry, including CSR single-use bioreactors up to 6,000L, stainless-steel bioreactors and fermenters from pilot scale to 30,000L+, and integrated hybrid single-use/stainless-steel platforms. The company also delivers comprehensive lifecycle services including outsourced maintenance, vessel services, modifications and retrofits, parts supply, automation support, engineering and consulting, and process science support through a global network of 3,000 service technicians.

Product overview

ABEC is a global provider of customized biopharmaceutical manufacturing solutions offering a comprehensive portfolio of products and services. The core offerings include CSR® Single-Use Systems (custom single-run bioreactors up to 6,000L), Stainless-Steel Systems (bioreactors and fermenters from pilot to 30,000L+), and Hybrid BioProcessing (integrated single-use and stainless-steel solutions). The Advanced Therapy Bioreactor (ATB™) supports cell and gene therapy workflows. Supporting services include Process Sciences (modeling, testing, validation), Automation (Synaptic™ HMI with platform support), and full lifecycle services including Outsourced Maintenance, Vessel Services, Modifications & Retrofits, Part Supply, Automation Support, and Engineering & Consulting. The Flexible Manufacturing Platform provides modular plant design combining all technologies.

Differentiator

Problem solved

Functional benefit

Brands

• Advanced Therapy Bioreactor (ATB™): Closed, automated single-use platform designed to support sensitive, perfusion-driven advanced therapy processes
• CSR® Custom Single Run
• Flexible Manufacturing Platform (FMP)

Products and services

• CSR® Single-Use Systems Custom Single Run (CSR) single-use bioreactors and fermenters engineered to deliver stainless-steel performance with single-use agility, supporting scalable multi-product operations with validated mixing, mass transfer, and predictable results. The product line spans up to 6,000L single-use systems enabling commercial-scale production. Targeted at biopharmaceutical manufacturers, CMOs, and advanced therapy developers.
• Stainless-Steel Systems Long-life engineered stainless-steel bioreactors and fermenters designed for reliability, reproducibility, and decades of continuous commercial-scale manufacturing. The product line spans pilot scale to 30,000L+ with patented fermenter design for large-scale cGMP processing. Targeted at biopharmaceutical manufacturers requiring durable, long-life production assets.
• Hybrid BioProcessing Integrated hybrid solutions combining the flexibility of single-use with the durability of stainless steel, designed for evolving pipelines and multi-product facilities. Delivers adaptability without sacrificing performance. Targeted at biopharma manufacturers with multi-product facilities needing flexibility and durability.
• Advanced Therapy Bioreactor (ATB™) Closed, automated single-use bioreactor platform designed for sensitive, perfusion-driven advanced therapy workflows, providing controlled, reproducible performance for cell and gene therapy development and scale-out from 0.2L to 10L. Targeted at cell and gene therapy developers including CAR-T and other advanced therapy manufacturers.
• Automation (Synaptic™ HMI) Integrated automation systems with Synaptic HMI approach supporting Emerson DeltaV, Rockwell PlantPAx, and other supplier platforms, designed to deliver consistent control, reduce variability, and sustain performance across facilities. Targeted at biopharmaceutical manufacturers operating multi-platform automation environments.
• Outsourced Maintenance Proactive maintenance programs across single-use, stainless-steel, and hybrid bioprocess systems to maximize uptime, extend asset life, and reduce unplanned work. Delivered globally through 3,000 service technicians performing 10,000+ preventative maintenance actions per year. Targeted at biopharmaceutical manufacturers operating ABEC and select third-party bioprocess equipment.
• Vessel Services Vessel inspection, restoration, and upgrade services including comprehensive inspection, surface remediation, electropolishing, and mechanical polishing to maintain vessel integrity across full lifecycle. Targeted at biopharmaceutical manufacturers needing vessel integrity assurance over decades of operation.
• Modifications & Retrofits Engineering-led modifications and retrofits for bioprocess platforms including process/mechanical modifications, agitation & mixing enhancements, thermal upgrades, automation & control updates, and CSR single-use hardware modifications. Targeted at existing biopharmaceutical manufacturers extending or modernizing installed ABEC systems.
• Part Supply OEM components and qualified replacement parts with traceability, supporting both ABEC-built equipment and select third-party systems, including critical spares programs and expedited fulfillment. Access to 20,000+ parts shipped 7 days a week. Targeted at biopharmaceutical manufacturers needing reliable spare parts supply.
• Automation Support Lifecycle automation support including diagnostics, troubleshooting, platform updates & upgrades, legacy system modernization, recipe & control strategy updates, and configuration management. Targeted at biopharmaceutical manufacturers running ABEC automation platforms across multiple DCS environments.
• Engineering & Consulting Manufacturing-first engineering consulting including process definition, system architecture & platform selection, facility planning, scale-up strategy, and technology evaluation. Targeted at biopharmaceutical manufacturers planning new facilities or major capacity expansions.
• Process Science Support Process characterization, performance validation, risk reduction & optimization services including mixing & mass transfer evaluation, scale-up analysis, process modeling, and comparability studies. Targeted at biopharmaceutical manufacturers requiring scale-up de-risking and process validation.
• Flexible Manufacturing Platform (FMP) Hybrid, modular, integrated plant design combining single-use and stainless steel capabilities that can scale production capacity when market conditions are met, mitigating capacity investment risks. Targeted at biopharmaceutical manufacturers seeking flexible, modular facility capacity.

Quantifiable outcome

• 40-50% CAPEX reduction with single-use systems vs. stainless steel
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators9 records

Recent moves14 records

Expansion highlights5 records

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCRTDJg3O_XtK-YX4WCgaXDg
• Facebookfacebook.com/abecinc
• LinkedInlinkedin.com/company/abec

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ABEC